Repertoire Immune Medicines Secures $189M Financing To Advance Pipeline Programs And Discovery Platform Directed At Cellular Immune Targets
Amount Raised
$189 Million
Round Type
Funding Round
CambridgeBiotechnologyHealth CareTherapeuticsDescription
Repertoire Immune Medicines, a clinical-stage biotech company decoding the immune synapse to create novel immune therapies for cancer, immune disorders, infectious disease, and other serious diseases, today announced the completion of a $189 million Series B financing. Joining Flagship Pioneering, Repertoire’s institutional founder and principal backer, are new and existing investors including Softbank Vision Fund 2i, the Public Sector Pension Investment Board (PSP Investments), the Alaska Permanent Fund, Invus, and others. Proceeds from this financing will support further expansion of the company’s proprietary DECODE discovery platform, accelerate its clinical and preclinical pipeline, expand Repertoire’s team, and enhance its manufacturing capabilities. Founded by Flagship Pioneering, Repertoire has raised more than $350 million in the aggregate to date.
Quick answer
Repertoire Immune Medicines raised $189 Million in a Funding Round round, dated April 13, 2021. Repertoire Immune Medicines is based in Cambridge, Massachusetts, United States.
- How much did Repertoire Immune Medicines raise?
- Repertoire Immune Medicines raised $189 Million in a Funding Round round on April 13, 2021.
- What does Repertoire Immune Medicines do?
- Repertoire Immune Medicines is a biotechnology company pioneering the discovery and development of programmable T cell-targeted immune medicines.
- Where is Repertoire Immune Medicines based and how big is it?
- Repertoire Immune Medicines is based in Cambridge, Massachusetts, United States. Fundz records about 83 employees.
- Who are the decision-makers at Repertoire Immune Medicines?
- Fundz holds 1 contact at Repertoire Immune Medicines. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who to call at Repertoire Immune Medicines, and when
A new round usually means Repertoire Immune Medicines is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Repertoire Immune Medicines raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Repertoire Immune Medicines, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Repertoire Immune Medicines. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Repertoire Immune Medicines raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Repertoire Immune Medicines raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.